Prevalence of chronic obstructive pulmonary disease in Indian nonsmokers: a systematic review & meta-analysis
Author:
Suri Tejas M.1, Ghosh Tamoghna2, Mittal Saurabh1, Hadda Vijay1, Madan Karan1, Mohan Anant1
Affiliation:
1. Department of Pulmonary, Critical Care and Sleep Medicine , All India Institute of Medical Sciences , New Delhi , India 2. Department of Medicine , All India Institute of Medical Sciences , New Delhi , India
Abstract
Abstract
Introduction
Nonsmokers with chronic obstructive pulmonary disease (COPD) are neglected despite constituting half of all cases in studies from the developed world. Herein, we systematically reviewed the prevalence of COPD among nonsmokers in India.
Content
We searched Embase, Scopus, and PubMed databases for studies examining the prevalence of COPD among nonsmokers in India. We used the Joanna Briggs Institute (JBI) checklist to assess included studies’ quality. Meta-analysis was performed using random-effects model.
Summary
Seven studies comprising 6,903 subjects were included. The quality of the studies ranged from 5/9 to 8/9. The prevalence of COPD varied between 1.6 and 26.6 %. Studies differed considerably in demographics and biomass exposure profiles of subjects. Among the four studies that enrolled both middle-aged and elderly Indian nonsmokers not screened based on biomass fuel exposure, the pooled prevalence of COPD was 3 % (95 % CI, 2–3 %; I2=50.52 %, p=0.11). The pooled prevalence of COPD among biomass fuel-exposed individuals was 10 % (95 % CI, 2–18 %; I2=98.8 %, p<0.001).
Outlook
Limited evidence suggests a sizable burden of COPD among nonsmokers and biomass fuel-exposed individuals in India. More epidemiological studies of COPD in nonsmokers are needed from low and middle-income countries.
Publisher
Walter de Gruyter GmbH
Subject
Public Health, Environmental and Occupational Health,Pollution,Health (social science)
Reference43 articles.
1. Adeloye, D, Song, P, Zhu, Y, Campbell, H, Sheikh, A, Rudan, I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022;10:447–58. https://doi.org/10.1016/s2213-2600(21)00511-7. 2. The top 10 causes of death [Internet]. [cited 2023 Oct 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. 3. Safiri, S, Carson-Chahhoud, K, Noori, M, Nejadghaderi, SA, Sullman, MJM, Ahmadian Heris, J, et al.. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. BMJ 2022;378:e069679. https://doi.org/10.1136/bmj-2021-069679. 4. Salvi, S, Kumar, GA, Dhaliwal, RS, Paulson, K, Agrawal, A, Koul, PA, et al.. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Global Health 2018;6:e1363–74. https://doi.org/10.1016/s2214-109x(18)30409-1. 5. Cunalata-Paredes, AV, Gea-Izquierdo, E. COPD in the major nonsmoking adult: a systematic review and meta-analysis. Arch Environ Occup Health 2021;76:319–29. https://doi.org/10.1080/19338244.2020.1828243.
|
|